Impact of cyclooxygenase-2 inhibitors: are they fulfilling their promises?
Yeomans
N D
ND
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000191:economics; D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000191:economics; D006801:Humans; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000191:economics / Q000517:prevention & control; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D016861:Cyclooxygenase Inhibitors